🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gastrointestinal Stromal Tumors

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) NCT07406633Phase 217 sites📍 Los Angeles📍 Jacksonville📍 Miami Kumquat Biosciences Inc. · Tests: KQB198, Imatinib (Gleevec) A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline) NCT07585266Phase 393 sites📍 Scottsdale📍 San Francisco📍 New Haven GlaxoSmithKline · Tests: Velzatinib, Imatinib The Efficacy and Safety of Temozolomide in SDH-deficient GIST NCT05661643Phase 21 site📍 Seoul Asan Medical Center · Tests: Temozolomide capsule Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Marsden360 ctDNA test and GTAB review LRG GIST Patient Registry NCT07697248n/a1 site📍 Wayne The Life Raft Group A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) NCT06630234Phase 1, Phase 210 sites📍 Scottsdate📍 La Jolla📍 Aurora Deciphera Pharmaceuticals, LLC · Tests: DCC-3009 ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST NCT05366816Phase 21 site📍 Miami University of Miami · Tests: Sunitinib, Regorafenib Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study NCT07522762n/a1 site📍 Amsterdam The Netherlands Cancer Institute 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk NCT05385549Phase 21 site📍 Seoul Asan Medical Center · Tests: Imatinib Mesylate Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients NCT07096609Phase 1, Phase 21 site📍 Seoul Asan Medical Center · Tests: Lenvatinib Capsules RCT of EFTR Versus STER for GIST Treatment NCT07411118NA4 sites📍 Shanghai📍 Hong Kong📍 Hyderabad Chinese University of Hong Kong · Tests: Endoscopic full thickness resection (EFTR) / Exposed non-tunneling EFTR, Submucosal Tunneling Endoscopic Resection (STE… Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA NCT05461664n/a1 site📍 Guangzhou Xinhua Zhang, MD Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Oxaliplatin, Leucovorin, Irinotecan Hydrochloride, 5-FU Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK NCT04181970n/a9 sites📍 Buenos Aires📍 São Paulo📍 Heredia Grupo Espanol de Investigacion en Sarcomas · Tests: Quality assessment A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites📍 Ann Arbor📍 Cleveland📍 Portland Novelty Nobility, Inc. · Tests: NN3201 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy NCT01416714n/a1 site📍 Chicago University of Chicago Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment NCT07559864Phase 21 site📍 Beijing Jian Li · Tests: physician-selected treatment, Regorafenib + Envafolimab Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis NCT04557969n/a1 site📍 Bethesda National Cancer Institute (NCI) A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib NCT07689201Phase 23 sites📍 Fukuoka📍 Hokkaido📍 Tokyo GlaxoSmithKline · Tests: Velzatinib A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis NCT07078136n/a1 site📍 Wuhan Huazhong University of Science and Technology · Tests: Multimodal AI Model, Expert Endoscopist Assessment Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma NCT01048281n/a1 site📍 Stanford Stanford University · Tests: Blood draw, Tissue tumor biopsy A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT06655246Phase 132 sites📍 Birmingham📍 Phoenix📍 La Jolla Kura Oncology, Inc. · Tests: ziftomenib, imatinib mesylate Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor NCT07171203Phase 11 site📍 La Jolla University of California, San Diego · Tests: Imatinib, Fampridine Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST NCT06507683NA1 site📍 Chongqing First Affiliated Hospital of Chongqing Medical University · Tests: simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten) NCT05009927Phase 213 sites📍 Besançon📍 Bordeaux📍 Limoges Centre Leon Berard · Tests: Imatinib tablets Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring NCT05500391Phase 23 sites📍 Amiens📍 Caen📍 Lille Centre Oscar Lambret · Tests: Oncological Follow-up Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT07379047Phase 2, Phase 332 sites📍 Hefei📍 Hefei📍 Beijing Ningbo Newbay Technology Development Co., Ltd · Tests: NB003, regorafenib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy